Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a...
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
ZEGFROVY ® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line treatment for advanced NSCLC with EGFR exon20ins WU-KONG28 is the first global randomized phase 3 study with positive results for an oral,...
RPX Corporation Announces Leadership Transition
Ryan Elliott to Succeed Dan McCurdy as Chief Executive Officer, Effective July 1 SAN FRANCISCO, May 28, 2026 /PRNewswire/ -- RPX Corporation, a leading patent risk management service provider, today announced that Ryan Elliott, industry veteran and...
Cheche Group Inc. Announces Notice of Intent by Founder and CEO Lei Zhang to Purchase Company Shares
BEIJING, May 28, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that its Founder and Chief Executive Officer, Mr. Lei Zhang, has expressed his...
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced that it plans to change the ratio of its American Depositary...
Fox ESS Announces Its Rebrand Ahead of SNEC Exhibition, Unveiling A New Brand Journey
WENZHOU, China, May 28, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable energy solutions, today announced its rebrand, an important step in the brand's ongoing journey of innovation, trust, and long-term commitment to a more resilient...
PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure
IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell...
LG ELECTRONICS ANNOUNCES NEW SOLUTIONS FOR AUTOMOTIVE INNOVATION PARTNERSHIP WITH GOOGLE
LG Reinforces Technology Leadership with IVI and SDV Technologies Delivering Seamless Multi-Display Experiences and Optimized Single-SoC Performance News Summary LG Electronics announced its latest AAOS and AAOS-based IVI and SDV solutions, earning...
Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease
SUZHOU, China and MÖLNDAL, Sweden, May 28, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (stock code 06938.HK) and Ribocure Pharmaceuticals (together "Ribo") announce the submission of Phase 2 Clinical Trial Application (CTA) to the European...
YY Group Holding Announces Estimated Total Assets and Net Assets per Share of $11.13 and $4.03, Respectively, as of April 30, 2026
Estimates Reflect $37.6M in Total Assets and $13.6M in Net Assets Based on 3.38M Shares Outstanding SINGAPORE, May 28, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), an AI-native workforce management...